Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Transcode Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +17 vs. Q2 2021
- Shares held
- 2.44M
- +2.44M vs. Q2 2021
- Total value
- $7.28M
- +$7.28M vs. Q2 2021
- New holders
- 17
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $208.1K |
| Q1 2026 | 8 | $265.7K |
| Q4 2025 | 6 | $26.4K |
| Q3 2025 | 8 | $155.0K |
| Q2 2025 | 9 | $237.0K |
| Q1 2025 | 19 | $1.06M |
| Q4 2024 | 5 | $33.4K |
| Q3 2024 | 10 | $185.8K |
| Q2 2024 | 15 | $263.0K |
| Q1 2024 | 7 | $284.1K |
| Q4 2023 | 13 | $105.4K |
| Q3 2023 | 11 | $281.6K |
| Q2 2023 | 5 | $476.6K |
| Q1 2023 | 11 | $88.6K |
| Q4 2022 | 18 | $222.5K |
| Q3 2022 | 13 | $2.27M |
| Q2 2022 | 13 | $2.67M |
| Q1 2022 | 13 | $3.14M |
| Q4 2021 | 16 | $5.98M |
| Q3 2021 | 17 | $7.28M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Transcode Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,270,500 | $3.80M | 1.07% | +1,270,500 | New |
| Kepos Capital LP | 300,000 | $897.0K | 0.06% | +300,000 | New |
| Worth Venture Partners, LLC | 295,518 | $884.0K | 0.40% | +295,518 | New |
| Vanguard Group Inc | 200,117 | $598.0K | 0.00% | +200,117 | New |
| Citadel Advisors LLC | 90,774 | $271.0K | 0.00% | +90,774 | New |
| Two Sigma Investments, LP | 76,645 | $229.0K | 0.00% | +76,645 | New |
| ACT Capital Management, LLC | 50,000 | $150.0K | 0.08% | +50,000 | New |
| Two Sigma Securities, LLC | 33,314 | $100.0K | 0.02% | +33,314 | New |
| National Asset Management, Inc. | 25,000 | $75.0K | 0.00% | +25,000 | New |
| State Street Corp | 20,600 | $62.0K | 0.00% | +20,600 | New |
| Virtu Financial LLC | 18,064 | $54.0K | 0.00% | +18,064 | New |
| Geode Capital Management, LLC | 17,023 | $50.0K | 0.00% | +17,023 | New |
| BlackRock Inc. | 16,366 | $49.0K | 0.00% | +16,366 | New |
| Shay Capital LLC | 15,060 | $45.0K | 0.01% | +15,060 | New |
| UBS Group AG | 5,337 | $16.0K | 0.00% | +5,337 | New |
| Tower Research Capital LLC (TRC) | 1,473 | $4.00K | 0.00% | +1,473 | New |
| Wells Fargo & Company | 38 | $0 | 0.00% | +38 | New |